Biomedical research at Oslo University Hospital

Oslo University Hospital is a merger of three former university hospitals in Oslo. Biomedical research is one of the hospital's core activities. Research at the hospital is closely interlinked with research undertaken at the University of Oslo. More than 50% of all biomedical research in Norway is published by researchers affiliated with the hospital. Research undertaken cover both basic research, translational research, and clinical research.

Oslo University Hospital has a central role in developing and supporting biomedical research within the South-Eastern Regional Health Authority. The hospital also pursues international research collaborations.

Click here to see hierarchical division and subunit overview

Summary of publications:

Publications (original articles or review articles) published in 2021 from OUS - Centre for Addiction Treatment

10 publications found

Bækkelund H, Karlsrud I, Hoffart A, Arnevik EA (2021)
Stabilizing group treatment for childhood-abuse related PTSD: a randomized controlled trial
Eur J Psychotraumatol, 12 (1), 1859079
DOI 10.1080/20008198.2020.1859079, PubMed 33537118

Bech AB, Clausen T, Waal H, Delaveris GJM, Skeie I (2021)
Organ pathologies detected post-mortem in patients receiving opioid agonist treatment for opioid use disorder: a nationwide 2-year cross-sectional study
Addiction (in press)
DOI 10.1111/add.15705, PubMed 34648218

Bjørnebekk A, Kaufmann T, Hauger LE, Klonteig S, Hullstein IR, Westlye LT (2021)
Long-term Anabolic-Androgenic Steroid Use Is Associated With Deviant Brain Aging
Biol Psychiatry Cogn Neurosci Neuroimaging, 6 (5), 579-589
DOI 10.1016/j.bpsc.2021.01.001, PubMed 33811018

Bukten A, Stavseth MR (2021)
Suicide in prison and after release: a 17-year national cohort study
Eur J Epidemiol, 36 (10), 1075-1083
DOI 10.1007/s10654-021-00782-0, PubMed 34427828

Finstad J, Røise O, Rosseland LA, Clausen T, Havnes IA (2021)
Discharge from the trauma centre: exposure to opioids, unmet information needs and lack of follow up-a qualitative study among physical trauma survivors
Scand J Trauma Resusc Emerg Med, 29 (1), 121
DOI 10.1186/s13049-021-00938-7, PubMed 34419130

Hauger LE, Havnes IA, Jørstad ML, Bjørnebekk A (2021)
Anabolic androgenic steroids, antisocial personality traits, aggression and violence
Drug Alcohol Depend, 221, 108604
DOI 10.1016/j.drugalcdep.2021.108604, PubMed 33621808

Kvarstein EH, Zahl KE, Stänicke LI, Pettersen MS, Baltzersen ÅL, Johansen MS, Eikenaes IU, Arnevik EA, Hummelen B, Wilberg T, Pedersen G (2021)
Vulnerability of personality disorder during the Covid-19 crises - a multicenter survey of treatment experiences among patients referred to treatment
Nord J Psychiatry
DOI 10.1080/08039488.2021.1934110, PubMed 34126854

Midgard H, Ulstein K, Backe Ø, Foshaug T, Sørli H, Vennesland K, Nilssen D, Dahl EH, Finbråten AK, Wüsthoff L, Dalgard O (2021)
Hepatitis C treatment and reinfection surveillance among people who inject drugs in a low-threshold program in Oslo, Norway
Int J Drug Policy, 103165 (in press)
DOI 10.1016/j.drugpo.2021.103165, PubMed 33642182

Rognli EB, Aas EM, Drake RE, Marsden J, Anders P, Bond GR, Lystad JU, Reme SE, Arnevik EA (2021)
The effect evaluation of Individual Placement and Support (IPS) for patients with substance use disorders: study protocol for a randomized controlled trial of IPS versus enhanced self-help
Trials, 22 (1), 705
DOI 10.1186/s13063-021-05673-z, PubMed 34654464

Rognli EB, Bramness JG, von Soest T (2021)
Smoking in early adulthood is prospectively associated with prescriptions of antipsychotics, mood stabilizers, antidepressants and anxiolytics
Psychol Med, 1-10 (in press)
DOI 10.1017/S0033291720005401, PubMed 33583454

 
Page visits: 656313